SCHEDULE: Innovex International: Major Shareholder Group Reduces Stake

Sentiment:

Beneficial Ownership Update


A group of investment funds led by Amberjack Capital Partners completed a secondary public offering of Innovex International shares, reducing their collective stake to 33.2% while the company simultaneously repurchased shares.

Summary

  • A group of selling stockholders, including Amberjack Capital Fund II, Innovex Co-Invest Funds, and Intervale Capital Funds, completed a secondary public offering of Innovex International, Inc. common stock.
  • The offering involved the sale of 5,750,000 shares at $25.75 per share, with the selling stockholders receiving $24.59125 per share after underwriting discounts.
  • Underwriters fully exercised a 30-day option to purchase an additional 862,500 shares, bringing the total shares sold by the selling stockholders to 6,612,500.
  • Innovex International, Inc. concurrently repurchased 575,000 shares from the underwriters as part of its existing share repurchase program.
  • The offering and share repurchase closed on February 27, 2026.
  • Following these transactions, the aggregate beneficial ownership of Amberjack Capital Partners, Amberjack Management, and Jason Turowsky in Innovex International, Inc. is 22,757,322 shares, representing 33.2% of the outstanding common stock.
  • The total outstanding shares of Innovex International, Inc. as of February 27, 2026, are 68,563,690.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event. While a large block sale by a major shareholder group can create selling pressure, the company's concurrent share repurchase demonstrates management's commitment to shareholder value and helps absorb some of the supply.

Positives

  • The company utilized its existing share repurchase program to buy back 575,000 shares, which can be accretive to earnings per share.
  • The secondary offering provided liquidity for the selling stockholders.
  • The offering price of $25.75 per share indicates a market valuation for the shares.

Negatives

  • A significant block of shares (6,612,500) was sold by a major shareholder group, which could put downward pressure on the stock price due to increased supply.
  • The selling stockholders received a discounted price of $24.59125 per share compared to the public offering price of $25.75, reflecting underwriting costs.

Risks

  • Increased supply of shares in the market from the secondary offering could lead to price volatility or downward pressure on Innovex International, Inc.'s stock price.
  • The concentration of ownership, even after the sale, by the Amberjack Capital group (33.2%) could still influence corporate decisions.

Future Outlook

Selling stockholders are subject to a 45-day lock-up period, restricting further sales of Innovex International, Inc. common stock or related securities without underwriter consent, which will expire around mid-April 2026.

Industry Context

StockSavvy.ai notes that secondary offerings by significant institutional investors are common mechanisms for private equity or venture capital funds to monetize their investments in publicly traded companies. The concurrent share repurchase by Innovex International, Inc. suggests management's confidence in the company's valuation and an effort to mitigate potential dilution or downward price pressure from the large block sale.

Related Party Transactions

  • The secondary offering involved "Seller Stockholders" (Amberjack Capital Fund II, Innovex Co-Invest Fund, Innovex Co-Invest Fund II, Intervale Capital Fund II, Intervale Capital Fund II-A, Intervale Capital Fund III) who are related parties to the reporting persons and collectively represent a significant ownership stake.
  • Jason Turowsky, as managing partner of Amberjack Management, is deemed a beneficial owner of the entire group's holdings, indicating a related party relationship.

Stakeholder Impact

  • Shareholders: Existing shareholders may experience short-term price volatility due to the large block sale, but the company's share repurchase could provide some support. The reduction in a major shareholder's stake could also be seen as reducing concentration risk or, conversely, a loss of a significant institutional backer.
  • Selling Stockholders: These entities successfully monetized a portion of their investment in Innovex International, Inc.

Next Steps

  • The 45-day lock-up period for the selling stockholders will conclude around April 13, 2026, after which they may be able to sell additional shares.

Key Dates

DateDescription
September 13, 2024Original Schedule 13D filed by the undersigned.
March 6, 2025Amendment No. 1 to Schedule 13D filed.
February 25, 2026Issuer entered into an Underwriting Agreement and a Lock-up Agreement with Selling Stockholders and Underwriters.
February 27, 2026Underwriters exercised the option in full; Offering and Share Repurchase closed; Date of outstanding shares calculation.

Recommendation

hold

The secondary offering by a major shareholder group introduces a significant supply of shares to the market, which could exert downward pressure. However, the concurrent share repurchase by Innovex International, Inc. demonstrates management's confidence and provides a counterbalancing force. The lock-up period offers a temporary reprieve from further sales by these specific entities. Given these offsetting factors, a 'hold' recommendation is appropriate, advising investors to monitor market absorption of the sold shares and the company's future performance.

Keywords

Innovex International, Amberjack Capital Partners, Secondary Offering, Share Repurchase, Schedule 13D, Common Stock, Public Offering, Underwriting Agreement, Lock-up Agreement, Beneficial Ownership, J.P. Morgan Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.